Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells
Introduction
Ceramide is a sphingolipid second messenger that is involved in mediating a variety of cell functions including growth arrest, differentiation and apoptosis [1], [2], [3]. A number of diverse apoptosis-inducing agents such as tumor necrosis factor-α, chemotherapeutic agents, Fas ligation, irradiation, and corticosteroids generate ceramide by hydrolysis of membrane sphingomyelin by sphingomyelinases or by de novo synthesis [3], [4], [5], [6], [7]. Moreover, exogenous cell-permeable ceramide and endogenous ceramide generated by sphigomyelinase activation specifically induce apoptosis in many different cell types, suggesting that ceramide can act as a mediator of apoptosis.
Ceramide activates a number of signaling cascades including mitogen-activated protein kinases. Ceramide has also been shown to activate proapototic mechanisms by activating ceramide-activated phosphatases and ceramide-activated kinases, which in turn regulate PKC, Akt, and Bcl-2 family proteins [3], [8], [9]. It is well established that mitochondria are important in the control of apoptosis [10], [11], [12], and several studies have addressed the involvement of mitochondrial dysfunction in ceramide-mediated apoptosis. The regulation of mitochondrial membrane integrity and the release of cytochrome c from mitochondria are important processes during ceramide-mediated apoptosis [13], [14], [15]. Members of the antiapoptotic Bcl-2 family are key regulators of mitochondrial-dependent apoptosis. Of these, Bax is a critical regulator of the ceramide-induced apoptotic pathway, upstream of cytochrome c release. Ceramide induces mitochondrial translocation of Bax upon the induction of apoptosis in HL-60 cells [14]. Furthermore, ceramide-induced apoptosis is sensitized in Bax-transfected cells and inhibited by loss of Bax [16]. A recent study suggested that TNFα-mediated mitochondrial generation of ceramide is involved in translocation of Bax to mitochondria and subsequent release of cytochrome c and cell death [17], suggesting a role for the mitochondrial ceramide pool in the mitochondrial pathway of apoptosis.
Although Bax translocation plays a critical role in ceramide-induced apoptosis, the upstream signal transduction pathways that induce Bax translocation during ceramide-mediated apoptosis have not been well defined yet. Therefore, we investigated the regulation of Bax translocation in ceramide-induced apoptosis. The p38 mitogen-activated protein kinase (MAPK) is known as a potential upstream regulator of Bax [18]. p38 MAPK is activated by a variety of cellular stresses including ultraviolet light, hyperosmolarity, heat shock, and proinflammatory cytokines, and acts at early step prior to dysfunction of mitochondria and caspase activation [19], [20], [21]. Translocation of Bax can be also modulated by the PI3K-Akt pathway, which is one of the important pathways that are critical in cell survival [22], [23]. Akt is known to inhibit apoptosis by inactivating proapoptotic proteins such as Bad, procaspase-9, and forkhead and by activating antiapoptotic proteins such as NFκB and cyclic adenosine monophosphate (cAMP)-response element binding protein [24], [25], [26].
Recent studies have shown that ceramide-induced apoptosis is associated with activation of stress-activated protein kinase p38 MAPK [13], [27], and inactivation of Akt kinase pathway [28], [29]. Therefore, we asked whether p38 MAPK and Akt kinase are involved in the regulation of ceramide-induced mitochondrial Bax translocation. We found that activation of p38 MAPK is critical for the induction of apoptosis and Bax subcellular redistribution, and also demonstrated that Akt is capable of suppressing Bax translocation to mitochondria during ceramide-induced apoptosis in HL-60 cells. Furthermore, the present data showed that inactivation of p38 MAPK inhibits ceramide-induced dephosphorylation of Akt, indicating p38MAPK functions as an upstream regulator of Akt.
Section snippets
Reagents and antibodies
Fetal bovine serum was purchased from WEL GENE (Daegu, Korea), and the ECL kit was from Amersham Pharmacia. C6-ceramide, SB203580, and LY294002 were from Sigma Chemical Co. (St. Louis, MO, USA), and caspase-3 substrate from Biomol (Plymouth Meeting, PA, USA). Antibodies to cytochrome c and PI3 kinase (p85, p110α) were from Cell Signaling Technology (Beverly, MA, USA), and antibodies to p38 MAPK, phospho-p38, Bax, Akt, pAkt (Ser473), and HRP-conjugated secondary antibody were from Santa Cruz
p38 MAPK is involved in ceramide-induced apoptosis in HL-60 cells
Previously, we reported that ceramide induced apoptosis through caspase activation, cytochrome c release, and Bax translocation in HL-60 cells [14]. Since there is an evidence that p38 MAPK acts at an early step prior to mitochondrial dysfunction and caspase activation [18], we analyzed the involvement of p38 MAPK activation in ceramide-mediated apoptosis to elucidate the signaling events that mediate these events. Consistent with previous results in other cell lines [13], [15], [27], treatment
Discussion
Previous studies have implicated p38 MAPK and Akt as regulators of mitochondria-dependent apoptosis. Because ceramide modulates the activity of p38 MAPK and Akt in various cell systems, we hypothesized that these signaling pathways may be involved in ceramide-induced mitochondria-dependent apoptosis. In this study, we provided evidence for the role of p38 MAPK in ceramide-induced apoptosis in HL-60 cells. The present study showed that ceramide induced apoptosis, caspase-3 activation, Bax
Acknowledgements
This work was supported by Grants, from the Basic Research Program of the Korea Science and Engineering Foundation, R01-2003-000-10855-0, and the Strategic Research Program of Chung-Ang University.
References (39)
- et al.
The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind
J. Biol. Chem.
(2002) - et al.
Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon
J. Biol. Chem.
(1991) - et al.
Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A activation is stereospecific and regulated by phosphatidic acid
J. Biol. Chem.
(1999) - et al.
Bcl-2-family proteins and the role of mitochondria in apoptosis
Curr. Opin. Cell Biol.
(2003) - et al.
Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins
Mol. Cell. Neurosci.
(2005) - et al.
Bax-dependent apoptosis induced by ceramide in HL-60 cells
FEBS Lett.
(2001) - et al.
p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-xL
Exp. Cell Res.
(2004) - et al.
The phosphatidylinositol 3-kinase (PI3)-Akt pathway suppresses Bax translocation to mitochondria
J. Biol. Chem.
(2002) - et al.
Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis
J. Biol. Chem.
(1998) - et al.
Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ, Implications for growth arrest
J. Biol. Chem.
(2002)
Activation of the pro-survival phosphatidylinositol 3-kinase/Akt pathway by transforming growth factor-β1 in mesenchymeal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor
J. Biol. Chem.
Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols
J. Biol. Chem.
Sphingomyelinase metabolites control survival and apoptotic death in SH-SY5Y neuroblastoma cells
Neurosci. Lett.
Role for neutral sphingomyelinase-2 (nSMase2) in TNF-α-stimulated expression of VCAM and ICAM in lung epithelial cells: p38 MAPK is an upstream regulator of nSMse2
J. Biol. Chem.
Nicotine inactivation of the proapototic function of Bax through phosphorylation
J. Biol. Chem.
Programmed cell death by ceramide
Science
Functions of ceramide in coordinating cellular responses to stress
Science
Daunorubicin induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis
EMBO J.
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
EMBO J.
Cited by (67)
The inhibition of p38 MAPK blocked inflammation to restore the functions of rat meibomian gland epithelial cells
2023, Experimental Eye ResearchDeoxynivalenol hijacks the pathway of Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT-3) to drive caspase-3-mediated apoptosis in intestinal porcine epithelial cells
2023, Science of the Total EnvironmentCitation Excerpt :Akt, a robust intracellular pro-survival signal, acts as an anti-apoptotic factor by regulating members of the Bcl-2 family or directly inhibits caspase-9 protease activity (Chen et al., 2022b). Akt's activity can be enhanced by Erk1/2 MAPK (Guan et al., 2015), whereas p38 MAPK might partake in its inactivation (Kim et al., 2008). As a downstream target of Akt, FoxO1, a member of the FoxO subfamily of forkhead transcription factors (Zhang et al., 2011), was phosphorylated with its nuclear exclusion resulting in a decrease in the transcriptional activity of the pro-apoptotic Bcl-2 family, promoting the cellular survival pathways.
A polysaccharide from Grifola frondosa fruit body induces HT-29 cells apoptosis by PI3K/AKT-MAPKs and NF-κB-pathway
2020, International Journal of Biological MacromoleculesInclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity
2019, PhytomedicineCitation Excerpt :On the other hand, ERK may negatively regulate PI3K/Akt activity through modulating the phosphorylation level of Grb2-associated binder-1 (Gab1) protein (Yu et al., 2002). In addition, the Akt and p38 pathways have been shown to negatively regulate each other (Gratton et al., 2001; Kim et al., 2008). Furthermore, crosstalk between the PI3K/Akt and JNK pathways may occur in both malignant and non-malignant cells (Liu et al., 2002).
P38 MAP kinase is involved in oleuropein-induced apoptosis in A549 cells by a mitochondrial apoptotic cascade
2017, Biomedicine and Pharmacotherapy